Abstract 12823: Efficacy, Optimal Duration and Safety of Adjunctive Cilostazol in Acute ST-elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention With Drug-Eluting Stents; a Multicenter, Randomized, Open Label, Phase 4 Trial

Soohyung Park,Byoung Geol Choi,Se Yeon Choi,Jae Kyeong Byun,Jinah Cha,Kyu-Ho Lee,SeungMin Back,Jieun Lee,Dong Kang,Ji Bak Kim,Jah Choi,Seung Young Roh,Jin O. Na,Cheol Ung Choi,Eung Ju Kim,Chang Gyu Park,Hong Seog Seo,Seung-Woon Rha

Abstract 12823: Efficacy, Optimal Duration and Safety of Adjunctive Cilostazol in Acute ST-elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention With Drug-Eluting Stents; a Multicenter, Randomized, Open Label, Phase 4 Trial

2021

Soohyung Park
Byoung Geol Choi
Se Yeon Choi
Jae Kyeong Byun
Jinah Cha
Kyu-Ho Lee
SeungMin Back
Jieun Lee
Dong Kang
Ji Bak Kim
Jah Choi
Seung Young Roh
Jin O. Na
Cheol Ung Choi
Eung Ju Kim
Chang Gyu Park
Hong Seog Seo
Seung-Woon Rha

Background: Previous studies showed that the triple antiplatelet therapy (TAT) which is an addition of cilostazol on the top of conventional dual antiplatelet therapy (DAT, aspirin + clopidogrel) w...

Keywords:

Percutaneous coronary intervention
Cardiology
Drug
Cilostazol
st elevation myocardial infarction
Clopidogrel
Internal medicine
Aspirin
open label
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations